Skip to NavigationSkip to content

News

New CEO for Teva, massive global staff cuts for Lilly, and 'pharma bro' Martin Shkreli finally heads to jail - check out the week's ten most popular...
Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing it has received...
The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer in the US – Amgen’s Mvasi (...
GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its Trelegy Ellipta treatment for...
Sandoz has unveiled new Phase 3 data confirming the efficacy and safety profile of its biosimilar adalimumab is on par with its reference product,...
Forxiga is AstraZeneca’s treatment for those living with type 2 diabetes but the results from a new trial have found that the pill may have benefits...
The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting the nod, after voting swung 11-0...
Novo Nordisk has unveiled new data on its diabetes treatment Xultophy (insulin degludec/liraglutide) which supports its efficacy in reducing risk...
Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that he will now go to jail....
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches